|

Becotatug Vedotin Clinical Trials

2 actively recruiting trials

Pipeline

Phase 3: 2

Top Sponsors

  • Ming-Yuan Chen1
  • First Affiliated Hospital of Guangxi Medical University1

Indications

  • Cancer2
  • Oligo-metastatic Cancer1
  • Nasopharyngeal Carcinoma (NPC)1

Other2 trials

Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC
Phase 3
Efficacy and Safety of SBRT Combined With Becotatug Vedotin (MRG003) in EGFR-Positive Metastatic Tumor Patients With Oligometastases
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.